Shares of Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $6.35 and traded as low as $6.30. Mannatech shares last traded at $6.30, with a volume of 31,321 shares traded.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. Weiss Ratings raised Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, October 29th. Wall Street Zen raised Mannatech to a “buy” rating in a report on Saturday, November 7th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.
View Our Latest Research Report on MTEX
Mannatech Stock Down 29.8%
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported $4.61 earnings per share for the quarter. The company had revenue of $24.87 million for the quarter. Mannatech had a negative net margin of 0.41% and a negative return on equity of 2,383.34%.
About Mannatech
Mannatech, Incorporated is a wellness company that develops and sells nutritional supplements, skincare products and other personal-care items. Its product portfolio includes supplements featuring plant-based ingredients and products marketed under brands such as Ambrotose and PhytoMatrix. The company distributes its products primarily through a network of independent sales associates, supported by online sales channels. Mannatech was founded in 1994 and serves customers in the United States and international markets.
Read More
- Five stocks we like better than Mannatech
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
